Vulvar Cancer Surgical Treatment Complications Management; 5 Years Experience, SECI

Background and Objectives: Vulvar cancer is a rare tumor accounts for approximately 3-5% of all gynaecological malignancies and 1% of all cancers in women, with incidence rate of 1-2/100,000. Typically these cancers occur in the seventh decade when comorbidity is common. The most prominent presenting symptom of vulvar cancer is localized pruritus.Vulvar cancer surgical treatment may has a number of short and long term complications. In our series which include twenty five patients; we will discuss the most common complications and how to avoid and treat them.In this series we will review our most common complications after surgical treatment of cancer vulva and how to avoid and treat them specially in the inguinal region.Patient and Methodes: This is retrospective study was conducted in Surgical Oncology Department, South Egypt cancer institute, Assiut University, from 2011-2014. Twenty five patients with proved vulvar cancer to whom surgical treatment was performed were included in our study and their data were retrospectively collected.Result: All patients in our series have squamous cell carcinoma as it is the commonest neoplasm that affects vulva. There is no operative related mortality. All complications are estimated per patient. Patients and tumor characteristics are reviewed. There are only significant difference in seroma formation (15.4% vs 66.7% respectively) p-value 0.01 and lymphedema (23.1% vs 75% respectively) p-value0.01. And there is significant difference in the incidence of wound breakdown (58.3% vs 15.4% respectively) p-value 0.05.Conclusion: Inguino-femoral dissection is an important step in surgical treatment of vulvar cancer but has many post-operative complications as wound dehiscence, seroma, cellulitis and lympedma which affect patient socio-psychological state and increase hospital stay.